Charakterisierung und Funktionsanalyse der Bindungsdomaene für den Kofaktor VP35 der RNA-Polymerase L des Ebola-Virus

Das Ebolavirus Zaire (EBOVz) zählt zu den tödlichsten humanpathogenen Erregern, gegen die es weder ein Therapeutikum noch einen Impfstoff gibt. Replikation und Transkription des 19 kb umfassenden negativsträngigen RNA-Genoms basieren auf der Bildung eines aktiven RNA-abhängigen RNA-Polymerase-Komple...

Full description

Saved in:
Bibliographic Details
Main Author: Trunschke, Martina
Contributors: Renkawitz-Pohl, Renate (Prof. Dr.) (Thesis advisor)
Format: Doctoral Thesis
Published: Philipps-Universität Marburg 2008
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

Replication and transcription of the RNA genome of the highly pathogenic Ebola virus (EBOV) is based on the reconstitution of active RNA-dependent RNA polymerase complexes consisting of the catalytical subunit of the polymerase L and the polymerase cofactor VP35. For replication and transcription, this complex has to interact with the RNA genome which is tightly encapsidated by NP. The L protein acts as a key-enzyme in this process. In this study, complex formation dependent on the interaction of L and VP35 was investigated. Furthermore, L-deletion mutants were tested for their ability to inhibit EBOV replication and transcription. Coexpression studies revealed that L did not interact with NP directly but was relocalized in NP-derived inclusion bodies by binding to VP35. Further investigations using co-immunoprecipitation assays and immunofluorescence analysis could show that the binding domain for VP35 is located within the aminoterminal part of L between amino acid 280 and 380. Stabilization of this complex occurs by interaction of VP35 with an additional part of L comprising amino acid 240 to 280. L-L complex formation was shown to occur in the absence of VP35 and is mediated by an aminoterminally located binding domain. The homo-oligomerisation domain of L comprises amino acid 1 to 450. Finally, minigenom assays were performed to investigate inhibitory effects of L-deletion mutants on EBOV replication and transcription. Our data suggest that short L-fragments with at least 380 aminoterminal amino acids were able to efficiently block EBOV replication and transcription revealing the VP35 binding site on L as a potential target for the development of antiviral compounds.